Inventor · disambiguated record
Nikolai Khodarev
Also filed as: KHODAREV NIKOLAI · KHODAREV NIKOLAI N
5 granted patents·8 pending applications·39 citations·filing 2002–2019
77Inventor score
Top patents by PatentIndex Score
13 records- 0189US7892740B2Prognosis and therapy predictive markers and methods of useUNIV CHICAGO·Filed 2007·Granted Feb 22, 2011·20 cites·23 claims
- 0287US10421971B2Anti-tumor therapyUNIV CHICAGO·Filed 2014·Granted Sep 24, 2019·9 cites·18 claims
- 0386US9790504B2Anti-tumor therapyKHODAREV NIKOLAI·Filed 2014·Granted Oct 17, 2017·9 cites·5 claims
- 0470US7537894B2Methods and kits for monitoring Barrett's metaplasiaUNIV CHICAGO·Filed 2006·Granted May 26, 2009·1 cites·7 claims
- 0564US2019071679A1Anti-tumor therapyUNIV CHICAGO·Filed 2018·Application pending·0 cites
- 0657US2017298362A1Anti-tumor therapyUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 0754US10561708B2Anti-tumor therapyUNIV CHICAGO·Filed 2018·Granted Feb 18, 2020·0 cites·17 claims
- 0854US2013150258A1Prognosis and therapy predictive markers and methods of useUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 0950US2011200998A1Prognosis and Therapy Predictive Markers and Methods of UseUNIV CHICAGO·Filed 2011·Application pending·0 cites
- 1047US2021115519A1Methods and kits for diagnosis and triage of patients with colorectal liver metastasesUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 1146US2016367627A1Anti-tumor therapyKHODAREV NIKOLAI·Filed 2014·Application pending·0 cites
- 1241US2005048491A1Methods and kits for use in selecting approaches to treating cancerFiled 2002·Application pending·0 cites
- 1333US2017268001A1Rnas with tumor radio/chemo-sensitizing and immunomodulatory properties and methods of their preparation and applicationUNIV CHICAGO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nikolai Khodarev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →